Skip to content

Slow Yogic-Derived Breathing and Respiration and Cardiovascular Variability in Spinal Cord Injury Patients

Effect of Slow Breathing and Yogic-Derived Breathing on Respiration and Cardiovascular Variability in Spinal Cord Injury Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05480618
Acronym
SCOGA
Enrollment
17
Registered
2022-07-29
Start date
2022-08-22
Completion date
2024-01-20
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries, Slow Breathing

Keywords

resonance, yogic, pranayama, spinal cord injury

Brief summary

This research will aid in understanding of slow-breathing and its effect on heart rate and blood pressure in people with a spinal cord injury (SCI). This research will investigate if traditional 'yogic' breathing exercises can be performed by subjects with SCI and its influence on the cardiovascular system.

Detailed description

The relationship between respiratory patterns and cardiovascular variability in healthy persons has been previously studied. However, the impact of SCI on the interrelationships between the respiratory and cardiovascular systems remains relatively unstudied. The loss of autonomic control in SCI may mean that slow breathing has profound effects on cardiovascular variability. Hence, those with SCI may represent a population that could benefit from the potential physiologic effects of numerous yogic-based breathing patterns that can be applied anywhere any time. Hence, it is important to determine if slower breathing patterns can shift the cardiovascular control pattern to-wards important healthful effects. This physiological study will compare the effects of uncontrolled breathing and traditional yogic slow-breathing practices on cardiovascular variability in SCI patients.

Interventions

BEHAVIORALSlow Breathing

On two separate visits (on Day 1 and between Day 7 and 9 of their self-practice) the subject will be coached on yoga breathing techniques. The breathing techniques will be varied in: 1. frequency (between 0.25 and 0.1 Hz) 2. Inspiratory:Expiratory (I:E) ratio or 'Duty Cycle' 3. with and without ujjayi (yogic throat restriction) 4. with and without inspiratory/expiratory breath holding At the end of the first coaching visit the subject will be given a diary to record their own practice of the breathing techniques they were coached on.

Sponsors

Spaulding Rehabilitation Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study was a small prospective cohort (N = 12 out of 17 completed) study with a one-time unblinded intervention of 4 differing breathing techniques/ratios compared to spontaneous breathing. Patients will receive instruction on D1 and on D7 lasting about 45 minutes and a diary for self-practice. On D14 the participant will be asked to sequentially perform the directed breathing frequencies and ratios. The lab visit will last approximately 1.5 hours, during which beat-by-beat cardiovascular variables and breath-by-breath respiratory variables will be recorded. The total in-person time commitment (\ 4 hours) over the 14 days.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Age: 18-60 years old 2. Wheelchair user 3. Medically stable \& able to follow directions 4. Body mass index (18.5 - 35 kg/m2)

Exclusion criteria

1. BP \>140/90 mmHg 2. Current use of cardioactive medications (except medication to support blood pressure) 3. Current tobacco use 4. Significant arrhythmia 5. Coronary artery disease 6. Diabetes 7. Renal Disease 8. Cancer 9. Epilepsy or other neurological diseases

Design outcomes

Primary

MeasureTime frameDescription
HRV7 minutes of paced or unpaced breathingHeart rate variability assessed in the frequency domain during paced or unpaced breathing via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.
BPV7 minutes of paced or unpaced breathingSystolic blood pressure variability from a Finometer assessed in the frequency domain via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.
SpO27 minutes of paced or unpaced breathingPeripheral oxygen saturation during paced or unpaced breathing
Expired Carbon Dioxide (CO2)7 minutes of paced or unpaced breathingExpired CO2 from a nasal cannula

Countries

United States

Participant flow

Recruitment details

All participants had a spinal cord injury and were wheelchair users. After screening and signing an informed consent, participants receive instruction on how to perform the different breathing patterns (arms). After 2 instructional sessions and 2 weeks of practice on their own a study visit was scheduled. Participants completed all arms in a random order in a single study visit.

Pre-assignment details

17 individuals signed an informed consent. 12 completed a study visit. All breathing patterns/milestones were completed by the 12 individuals who completed the study.

Baseline characteristics

Characteristic
Age, Continuous33.25 Years
STANDARD_DEVIATION 5.97
Body Mass Index26.2 kg/m^2
STANDARD_DEVIATION 4.9
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
8 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 17
other
Total, other adverse events
0 / 17
serious
Total, serious adverse events
0 / 17

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026